Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Receivables - Net: 2017-2025

Historic Receivables - Net for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to $33.6 million.

  • Puma Biotechnology's Receivables - Net fell 39.42% to $33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.6 million, marking a year-over-year decrease of 39.42%. This contributed to the annual value of $32.4 million for FY2024, which is 33.55% down from last year.
  • As of Q3 2025, Puma Biotechnology's Receivables - Net stood at $33.6 million, which was up 28.49% from $26.1 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Receivables - Net ranged from a high of $55.4 million in Q3 2024 and a low of $23.8 million during Q3 2021.
  • Over the past 3 years, Puma Biotechnology's median Receivables - Net value was $31.2 million (recorded in 2023), while the average stood at $33.5 million.
  • In the last 5 years, Puma Biotechnology's Receivables - Net skyrocketed by 87.88% in 2024 and then slumped by 39.42% in 2025.
  • Over the past 5 years, Puma Biotechnology's Receivables - Net (Quarterly) stood at $32.5 million in 2021, then grew by 24.05% to $40.4 million in 2022, then rose by 20.74% to $48.7 million in 2023, then slumped by 33.55% to $32.4 million in 2024, then tumbled by 39.42% to $33.6 million in 2025.
  • Its Receivables - Net was $33.6 million in Q3 2025, compared to $26.1 million in Q2 2025 and $25.7 million in Q1 2025.